Chris Gibson is the Co-Founder and CEO of Recursion, a digital biology company focused on industrializing drug discovery using automation, artificial intelligence, biology, and chemistry. Under his leadership, Recursion has developed a proprietary database of biological data and is moving towards an autonomous prediction and learning system for drug discovery. Chris is dedicated to decoding biology to improve lives and also mentors and invests in diverse biotech founders with a passion for making a positive impact through science.